Navigation Links
American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
Date:2/7/2008

nded December 31, 2007 Compared to Quarter Ended December 31, 2006

-- Revenues increased 32% to $15.5 million from $11.8 million.

-- Operating income was $5.9 million, or 38% of revenues compared to

$3.5 million, or 30% of revenues.

-- Segment EBITDA was $7.1 million, or 46% of revenues, compared to

$4.8 million, or 41% of revenues.

The first quarter variances in Specialty Chemicals revenues reflect the following factors:

-- A 66% increase in Grade I AP volume in the fiscal 2008 first quarter,

offset partially by a 15% decrease in the related average price per

pound.

-- Sodium azide revenues decreased 93% in the fiscal 2008 first quarter

compared to the prior year quarter.

-- Halotron revenues decreased 11% in the fiscal 2008 first quarter

compared to the prior year quarter.

The increase in Grade I AP volume for the fiscal 2008 first quarter compared to the prior fiscal year first quarter reflects the timing of customer orders. The fiscal 2008 first quarter included a greater percentage of our expected annual volume for fiscal 2008. On an annual basis, we expect fiscal 2008 volume to be comparable to fiscal 2007. There are numerous variations of Grade I AP that we produce for our customers. The decrease in the average price per pound of Grade I AP sold in the fiscal 2008 first quarter reflects a product mix that included more of the standard blend of Grade I AP than specialized blends.

Over the longer term, we expect demand for Grade I AP to be within the ranges of fiscal years 2006 and 2007. In addition, Grade I AP revenues are typically derived from a relatively few large orders. As a result, quarterly revenue amounts can vary significantly depending on the timing of individual orders throughout the year. Average price per pound may continue to fluctuate somewhat in future periods, depending upon product mix and volume.

The decrease
'/>"/>

SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
2. American Red Cross Responds to Tornadoes in the Southeast
3. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
4. Massive American Red Cross Tornado Relief Effort Spans Five States
5. Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns
6. Vitals.com Goes Red for American Heart Month
7. American Heart Month: Cracking Open Heart Health Myths
8. Consumer Reports Poll: Americans Demand Health Reform But Are Unsure About How to Achieve it
9. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
10. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
11. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)...gn is a collaborative effort by the National Assoc... Midwives Alliance of North America (MANA), Citize...raditional Childbearing (ICTC), North American Reg...ion Accreditation Council (MEAC). To celebrate a ...federal recognition of CPMs language beneficial to...
(Date:12/4/2009)...swire/ -- Medithrive, Inc. has won the Patient,s C...ay Area by popular vote conducted by the online we...hs in operation, the SF Bay community has selected...ng medicinal marijuana. ,, The rapid rise and...dispensary which caters to the consumer, provides ...
(Date:12/4/2009)...h., Dec. 4 The Editorial Advisory ...g Magazine today announced Allergan, Inc. (NYSE...d C.R. Bard, Inc. (NYSE: BCR ) as its February...onal and educational use. ,, "The committee cho...ing its flagship drug Botox and other products as ...
(Date:12/4/2009)...hows that muscle cells grown in the lab can restor... The work, performed in dogs and rats, might ultim...gastric reflux and fecal incontinence. , This te...h are the bands of muscle that separate the major ...se areas can cause gastrointestinal esophageal ref...
(Date:12/4/2009)...is a phenomenon that was started by people that we... dental work in the US, Canada, and other countrie...eople have found that Mexican Dental Vacation is a... (PRWEB) December 4, 2009 -...exican Dental Vacation is seeing their best year e...
Breaking Medicine News(10 mins):Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...soon be available for vegetarians. It is possible ...sages, from the cells taken from cow, chicken, pig...e animal would not only reduce the need for the an...ilored to be healthier than farm raised meat, whil...
... and affected at least 20 deployed to fight Maoist...ceman said Saturday. The state government has d...ed Police // in three villages of Sambalpur distri...ean water," said Raju Barali, who is suffering fro...
...tah School of Medicine had reported that a key pro...lets. These are unique cells that are unusual beca... Scientists long have thought the transformation ...ecursor cell that forms platelets and platelets is...
...erotic images have been known to cause momentary p...that there are limits to how much information peop... As a consequence of this, we often miss visual im...n also miss what we are searching for if we are sh...
...niversity of Washington, Seattle, and colleagues, ...Alzheimer’s disease. Moderately elevated levels o...ers and beta-amyloid // in plasma and in cerebrosp... years, the investigators raised blood insulin lev...
...cular Biology (CCMB), Hyderabad has unraveled the ...detecting the mechanisms that prevent cancer in hu...a and Utpal Bhadra have been instrumental behind t...romatin), which are responsible for rapid cell div...
Other Medicine News:
(Date:12/4/2009)..., , DURHAM, N.C., Dec. 4 /PRNewswire-FirstCal...oard: OXBT) today announced that the first patient...se escalation, clinical trial in Switzerland for u...ry (TBI). Oxycyte is the Company,s perfluorocarbon...al is of invaluable importance in improving the ou...
(Date:12/4/2009)..., , ANNAPOLIS, Md., Dec. 4 /PRNewswire-Firs...biodefense company developing medical countermeasu...nced today the presentation of new data from the C...lyophilized recombinant Protective Antigen (rPA) b...tent after 16 months at various temperatures up to...
(Date:12/4/2009)..., , Opposes use of imported drugs often sto... Dec. 4 Today, the seni...efeat the Dorgan Importation plan encompassed in S..."Senator Dorgan,s importation amendment is poised ...g system to be breached, and our health to be enda...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 1Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 3Thomson Reuters Joins the InChI Trust 13612 1Thomson Reuters Joins the InChI Trust 13612 27 Easy Tips for Healthy Aging 54745 17 Easy Tips for Healthy Aging 54745 2
...et, Inc. (Nasdaq:,MITI), a biopharmaceutical compa...e treatment of cancer, inflammation and autoimmune...1) showing cytotoxic activity of,anti-EpCAM antibo... colon,cancer cells on November 1, 2008 at the 23r...Biological Therapy of Cancer (iSBTc) , taking,plac...
...ionovo, Inc.,(Nasdaq: BNVI ) announced today that...BZL101, will advance to Phase 2 clinical testing a... clinical trial., The Phase 1B clinical trial was...of BZL101 and to determine the safety and feasibil...ment. A total of 27 women with,metastatic breast c...
Other Medicine Technology:Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 2Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 3Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 4Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 5Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4
J Cortex Extrator - Angled Right
J Cannula
J Hydrodissector - Newman
Side Cutting Cystotome
Medicine Products: